Vanguard Group’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$13.9M Buy
1,136,933
+77,824
+7% +$1.27M ﹤0.01% 2792
2025
Q3
$21.7M Buy
1,059,109
+138,224
+15% +$2.19M ﹤0.01% 2582
2025
Q2
$12.4M Sell
920,885
-963
-0.1% -$10.5K ﹤0.01% 2792
2025
Q1
$7.98M Sell
921,848
-13,709
-1% -$83.8K ﹤0.01% 2971
2024
Q4
$4.55M Sell
935,557
-17,336
-2% -$96.9K ﹤0.01% 3312
2024
Q3
$7.36M Sell
952,893
-20,675
-2% -$184K ﹤0.01% 3107
2024
Q2
$9.74M Sell
973,568
-53,725
-5% -$590K ﹤0.01% 2944
2024
Q1
$12.5M Buy
1,027,293
+6,291
+0.6% +$91.2K ﹤0.01% 2842
2023
Q4
$14.6M Buy
1,021,002
+28,416
+3% +$273K ﹤0.01% 2744
2023
Q3
$7.72M Buy
992,586
+102,650
+12% +$1.12M ﹤0.01% 3041
2023
Q2
$12.7M Buy
889,936
+21,764
+3% +$310K ﹤0.01% 2812
2023
Q1
$12.7M Sell
868,172
-243,239
-22% -$4.07M ﹤0.01% 2809
2022
Q4
$18.7M Buy
1,111,411
+104,999
+10% +$1.82M ﹤0.01% 2655
2022
Q3
$14.9M Sell
1,006,412
-78,052
-7% -$1.54M ﹤0.01% 2757
2022
Q2
$29.7M Sell
1,084,464
-30,622
-3% -$907K ﹤0.01% 2446
2022
Q1
$42M Buy
1,115,086
+32,310
+3% +$1.43M ﹤0.01% 2393
2021
Q4
$67.3M Buy
1,082,776
+264,570
+32% +$20M ﹤0.01% 2186
2021
Q3
$70M Buy
818,206
+43,857
+6% +$2.75M ﹤0.01% 2176
2021
Q2
$47.9M Buy
774,349
+86,181
+13% +$4.39M ﹤0.01% 2397
2021
Q1
$33.5M Buy
688,168
+51,991
+8% +$2.51M ﹤0.01% 2524
2020
Q4
$19.8M Buy
636,177
+59,903
+10% +$1.47M ﹤0.01% 2636
2020
Q3
$12M Buy
576,274
+14,339
+3% +$246K ﹤0.01% 2699
2020
Q2
$7.32M Sell
561,935
-115,392
-17% -$1.25M ﹤0.01% 2917
2020
Q1
$6.14M Buy
677,327
+18,619
+3% +$177K ﹤0.01% 2866
2019
Q4
$6.76M Buy
658,708
+69,591
+12% +$789K ﹤0.01% 3051
2019
Q3
$8.53M Buy
589,117
+78,057
+15% +$1.21M ﹤0.01% 2895
2019
Q2
$8.28M Buy
511,060
+93,015
+22% +$1.26M ﹤0.01% 2966
2019
Q1
$5.32M Buy
418,045
+23,479
+6% +$305K ﹤0.01% 3126
2018
Q4
$4.33M Buy
394,566
+105,443
+36% +$1.56M ﹤0.01% 3133
2018
Q3
$5.2M Buy
+289,123
New +$3.64M ﹤0.01% 3222

Other funds holding OPRX